Related Experiment Video
Updated: Nov 3, 2025
13:00
Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
Published on: July 31, 2021
3.8K
Vaccination in pregnancy: Challenges and evidence-based solutions
Eliana Castillo1, Andrea Patey2, Noni MacDonald3
1Department of Medicine, University of Calgary, Canada; Department of Obstetrics and Gynaecology University of Calgary, Canada.
Summary
Vaccination in pregnancy protects both mothers and babies. Low uptake is linked to hesitancy, provider issues, safety concerns, and access barriers, requiring more patient-focused research.
Area of Science:
- Maternal and Child Health
- Vaccinology
- Public Health Policy
Background:
- Vaccination in pregnancy (VIP) offers dual protection against tetanus, influenza, and pertussis for mothers and infants.
- Low VIP uptake is a global concern, exacerbated by vaccine hesitancy, identified as a major threat to global health.
- Barriers to VIP, primarily studied in high-income countries, include lack of provider recommendation, safety concerns, and access limitations.
Purpose of the Study:
- To identify key barriers and facilitators influencing vaccination in pregnancy (VIP) uptake.
- To highlight the critical role of healthcare provider recommendations in promoting VIP.
- To emphasize the need for patient-focused research on strategies addressing provider and system-level barriers to VIP.
Main Methods:
- Review of existing research on barriers and facilitators for VIP, predominantly from high-income countries.
- Analysis of factors contributing to vaccine hesitancy in pregnant populations.
- Identification of gaps in evidence regarding effective strategies for improving VIP.
Main Results:
- Healthcare provider recommendation is the most significant facilitator for VIP across diverse socioeconomic groups.
- Lack of provider recommendation, safety concerns, and access issues are primary barriers to VIP.
- Current data on strategies to overcome these barriers are inconsistent, contradictory, or insufficient.
Conclusions:
- Addressing vaccine hesitancy and overcoming barriers are crucial for increasing VIP.
- Further patient-focused research is essential to develop evidence-based strategies for improving VIP.
- Sustainable VIP programs necessitate integrated continuous quality improvement initiatives.
Keywords:
Health knowledge, attitudes, practiceImmunizationImmunization programsImplementation sciencePregnancyVaccinationMore Related Videos
Related Concept Videos
01:51Vaccinations
48.0K
Overview
48.0K
01:22Development of Immunocompetence
542
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
542
01:07Teratogenicity
3.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.3K
01:30Cancer Vaccines
592
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
592
01:29Microorganisms in Medicine and Therapeutics
558
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
558
01:17Ethical Dilemmas I
1.3K
Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
1.3K